Nonsurgical therapy holds promise for basal cell carcinoma.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage* / Q000627:therapeutic use; D000287:Administration, Topical; D000634:Aminoquinolines / Q000008:administration & dosage* / Q000627:therapeutic use; D002280:Basal Cell Carcinoma / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D016207:Cytokines / Q000096:biosynthesis / Q000187:drug effects; D004334:Drug Administration Schedule; D006801:Humans; D000077271:Imiquimod; D007372:Interferons; D009824:Ointments; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D016207:Cytokines; D009824:Ointments; D007372:Interferons; D000077271:Imiquimod